missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Rekombinante Proteine
  4. Gibco™ Human IFN-beta Recombinant Protein, PeproTech®

Gibco™ Human IFN-beta Recombinant Protein, PeproTech®

Artikelnummer. 17801293
Change view
Click to view available options
Menge:
100 μg
2 x 500 μg
20 μg
250 μg
5 μg
50 μg
500 μg
Packungsgröße:
1 Milligramm
100 Mikrogramm
20 Mikrogramm
250 Mikrogramm
5 Mikrogramm
50 Mikrogramm
500 Mikrogramm
7 product options available for selection
Product selection table with 7 available options. Use arrow keys to navigate and Enter or Space to select.
Artikelnummer. Menge unitSize
17801293 100 μg 100 Mikrogramm
17851783 2 x 500 μg 1 Milligramm
17841783 20 μg 20 Mikrogramm
17820423 250 μg 250 Mikrogramm
17821073 500 μg 500 Mikrogramm
17881583 50 μg 50 Mikrogramm
17891783 5 μg 5 Mikrogramm
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 7 options available.
7 options
Dieser Artikel kann nicht zurückgegeben werden. Rückgaberichtlinie anzeigen
Product Code. 17801293 missing translation for 'mfr' Gibco™ missing translation for 'supplierNo' 30002BC100UG

Bitte Sie sich an, um diesen Artikel zu kaufen. Sie benötigen ein Web-Konto? Registrieren Sie sich noch heute!

This item is not returnable. View return policy

Description

Recombinant Protein

300-02BC-1MG will be provided as 2 x 500 μg (300-02BC-500UG). PeproTech's Recombinant Human IFN-beta is a 20.0 kDa protein containing 166 amino acid residues. Due to glycosylation, IFN-beta has an approximate MW of 22.3 kDa based on SDS-PAGE gel and Mass Spectrometry. *Human IFN-beta (Catalog Number 300-02BC) has replaced Human IFN-beta (Catalog Number 300-02B) This product is shipped at ambient temperature. For storage, handling and reconstitution information, please see the lot-specific Certificate of Analysis

Type I Interferons (IFN-alpha/beta) are produced primarily in response to viral infection by Natural IFN-producing cells (IPCs) as part of the host immune response. IFNs can also inhibit the development of tumors. IFN-beta binding results in the activation of the tyrosine kinases Jak1 and Tyk2, phosphorylation of members of the STAT family of transcription factors, and the transcription and expression of the immune response genes. More recently, several members of the toll-like receptor (TLR) family were found to stimulate the production IFN-beta. IFN-beta is currently used clinically for treatment of tumors, infections and multiple sclerosis.
TRUSTED_SUSTAINABILITY

Specifications

Zugriffsnummer P01574
Zur Verwendung mit (Anwendung) Control, Bioactivity
Zusammensetzung Protein with no preservative
Gen-ID (Entrez) 3456
Molekulargewicht 20 kDa
Name Human IFN-beta
Reinigungsverfahren Purified
Menge 100 μg
Quelle CHO cells
Lagerungsbedingungen -20°C
Kennzeichnung RUO
Endotoxin-Konzentration <1 EU/μg
Gen-Alias Fibroblast interferon; Ifb; IFF; IFN b; IFN β; IFNB; Ifnb1; IFNbeta; IFN-beta; IFNβ; Interferon; Interferon b; Interferon beta; interferon beta 1; interferon beta 1, fibroblast; interferon beta protein; interferon, beta 1; interferon, beta 1, fibroblast; interferon-beta; RP11-113D19.1
Gebräuchliche Bezeichnung IFN beta
Gensymbol Ifnb1
Biologische Aktivität Determined by a cytotoxicity assay using human TF-1 cells. The expected ED50 is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg
Produkttyp Protein
Konjugat Unconjugated
Rekombinant Recombinant
Sequenz MSYNLLGFLQ RSSNFQCQKL LWQLNGRLEY CLKDRMNFDI PEEIKQLQQF QKEDAALTIY EMLQNIFAIF RQDSSSTGWN ETIVENLLAN VYHQINHLKT VLEEKLEKED FTRGKLMSSL HLKRYYGRIL HYLKAKEYSH CAWTIVRVEI LRNFYFINRL TGYLRN
Inhalt und Lagerung -20°C
Aktivität Determined by a cytotoxicity assay using human TF-1 cells. The expected ED50 is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg.
Expressionssystem CHO cells
Form Lyophilized
Reinheits- oder Qualitätsgrad ≥ 95% by SDS-PAGE gel and HPLC analyses.
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.